Correlation Between Lyxor 1 and COMPUGROUP MEDSPADR

Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and COMPUGROUP MEDSPADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and COMPUGROUP MEDSPADR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyxor 1 and COMPUGROUP MEDSPADR 1, you can compare the effects of market volatilities on Lyxor 1 and COMPUGROUP MEDSPADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of COMPUGROUP MEDSPADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and COMPUGROUP MEDSPADR.

Diversification Opportunities for Lyxor 1 and COMPUGROUP MEDSPADR

0.69

Correlation Coefficient

Lyxor 1  COMPUGROUP MEDSPADR

Poor diversification

The 3 months correlation between Lyxor and COMPUGROUP is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and COMPUGROUP MEDSPADR 1 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMPUGROUP MEDSPADR and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with COMPUGROUP MEDSPADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMPUGROUP MEDSPADR has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and COMPUGROUP MEDSPADR go up and down completely randomly.

Pair Corralation between Lyxor 1 and COMPUGROUP MEDSPADR

Assuming the 90 days trading horizon Lyxor 1 is expected to generate 7.07 times less return on investment than COMPUGROUP MEDSPADR. But when comparing it to its historical volatility, Lyxor 1 is 8.04 times less risky than COMPUGROUP MEDSPADR. It trades about 0.15 of its potential returns per unit of risk. COMPUGROUP MEDSPADR 1 is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,350  in COMPUGROUP MEDSPADR 1 on September 14, 2024 and sell it today you would earn a total of  770.00  from holding COMPUGROUP MEDSPADR 1 or generate 57.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Lyxor 1   vs.  COMPUGROUP MEDSPADR 1

Lyxor 1

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor 1 are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Lyxor 1 may actually be approaching a critical reversion point that can send shares even higher in January 2025.

COMPUGROUP MEDSPADR

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in COMPUGROUP MEDSPADR 1 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, COMPUGROUP MEDSPADR reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lyxor 1 and COMPUGROUP MEDSPADR

The main advantage of trading using opposite Lyxor 1 and COMPUGROUP MEDSPADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, COMPUGROUP MEDSPADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMPUGROUP MEDSPADR will offset losses from the drop in COMPUGROUP MEDSPADR's long position.

The idea behind Lyxor 1 and COMPUGROUP MEDSPADR 1 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.